Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DiaMedica Therapeutics Inc. | Director | Voting Common Shares, no par value per share | 73.3K | $205K | $2.80 | Jan 3, 2023 | Direct |
Terns Pharmaceuticals, Inc. | Chief Executive Officer, Director | Stock Option (Right to buy) | 1.25M | Mar 1, 2024 | Direct | ||
Terns Pharmaceuticals, Inc. | Chief Executive Officer, Director | Restricted Stock Unit | 150K | Mar 1, 2024 | Direct | ||
Tenaya Therapeutics, Inc. | Director | Stock Option (Right to buy) | 14.8K | Jun 9, 2023 | Direct | ||
DiaMedica Therapeutics Inc. | Director | Stock Option (right to buy) | 13.2K | Jun 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TERN | Terns Pharmaceuticals, Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Chief Executive Officer, Director |
TERN | Terns Pharmaceuticals, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 15, 2024 | Chief Executive Officer, Director |
TNYA | Tenaya Therapeutics, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
DMAC | DiaMedica Therapeutics Inc. | Jan 3, 2023 | 1 | $26.2K | 4 | Jan 3, 2023 | Director |
TNYA | Tenaya Therapeutics, Inc. | Dec 5, 2022 | 1 | $0 | 4 | Dec 7, 2022 | Director |
TNYA | Tenaya Therapeutics, Inc. | Dec 5, 2022 | 0 | $0 | 3 | Dec 7, 2022 | Director |
DMAC | DiaMedica Therapeutics Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
DMAC | DiaMedica Therapeutics Inc. | Jan 3, 2022 | 1 | $40K | 4 | Jan 3, 2022 | Director |
DMAC | DiaMedica Therapeutics Inc. | Aug 16, 2021 | 1 | $142K | 4 | Aug 17, 2021 | Director |
DMAC | DiaMedica Therapeutics Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 16, 2021 | Director |
DMAC | DiaMedica Therapeutics Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 16, 2021 | Director |